# Efficacy and Safety of Different Initial Doses of Oral Propranolol in the Treatment of Ulcerated Infantile Hemangioma

> **NCT06798363** · PHASE2,PHASE3 · RECRUITING · sponsor: **West China Hospital** · enrollment: 40 (estimated)

## Conditions studied

- Infantile Hemangioma

## Interventions

- **DRUG:** propranolol

## Key facts

- **NCT ID:** NCT06798363
- **Lead sponsor:** West China Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-02
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-08-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06798363

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06798363, "Efficacy and Safety of Different Initial Doses of Oral Propranolol in the Treatment of Ulcerated Infantile Hemangioma". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT06798363. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*